Active ingredientPhenylbutazoneCat. No. P-P091-001CAS 50-33-9Family · Pharmaceutical analytical standards
Phenylbutazone
A non-steroidal anti-inflammatory drug derived from pyrazolidine, introduced for human use in 1949 against rheumatoid arthritis and gout; it is also used in veterinary medicine. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?In horses it is used for sprains, tendinitis, joint pain, arthritis and laminitis; its main metabolite, oxyphenbutazone, differs from it by a single hydroxyl group.
Go to the active ingredient →Active ingredientPhenylbutazoneCat. No. P-P091-001CAS 50-33-9
Pharmacopoeial impurityPhenylbutazone EP Impurity ACat. No. P-P091-002CAS 3583-64-0
Pharmacopoeial impurityPhenylbutazone EP Impurity BCat. No. P-P091-003CAS 16860-43-8
Pharmacopoeial impurityPhenylbutazone EP Impurity CCat. No. P-P091-004CAS 122-66-7
Pharmacopoeial impurityPhenylbutazone EP Impurity DCat. No. P-P091-005CAS 103-33-3
Pharmacopoeial impurityPhenylbutazone EP Impurity E DihydrochlorideCat. No. P-P091-006CAS 531-85-1
Isotopically labelledPhenylbutazone-d9Cat. No. P-P091-007CAS 1189479-75-1
Impurity2-oxo-N,N'-diphenylhexanehydrazideCat. No. P-P091-008CAS 30923-77-4No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substancePhenylbutazone CRSEDQM code P1200000Family PhenylbutazoneImpurityPhenylbutazone impurity B CRSEDQM code Y0000147Family PhenylbutazoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.